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Abstract 
Reticuloendothelial phagocytic and serum opsonic activity was evaluatad at terminal stages of tumour growth in rats 
transplanted subcutaneously with chondrosarcoma in an attempt to evaluate the role of opsonic protein(s) in governing 
liposome recognition and clearance by the macrophage system. The liver of the tumour-bearing animals manifested a 
decline in the uptake of multilamellar vesicles composed of egg phosphatidylcholine: cholesterol: dicetyl phosphate (mole 
ratio 7:2:1) from the blood when compared to healthy animals, In contrast, an increase in splenic clearance of liposomes 
was encountered in tumour-bearing rats. Studies with isolated liver non-parenchymal cells suggested that liposome 
recognition in both health and at terminal stages of cancer growth is influenced by a serum opsonin, which can be 
precipitated by 35-50c~ ammonium sulphate, as well as the concentratior f calcium levels in serum. Serum of healthy 
animals equally enhanced liposome recognition by the hepatic macrophages of both normal and tumour-beafing rats. In 
contrast, both cell populations manifested poor liposome recognition i  the presence of serum pooled from tumour-beafing 
animals and the results were comparable to the corresponding liposome-cell interaction in the absence of serum, The 
opsonic activity of serum derived from tumour-bearing rats could be demonstrated ither by prior dialysis of serum against 
de-ionized water or by addition of E(ITA. Liver phagocytes ofhealthy animals recognized more liposome in the presence of 
dialysed or EGTA-chelated tumour-serum than that of liver cells derived from turnout ransplanted rats. A significant 
increase in serum calcium concentration was found in all tumour-bearing rats. When the concentration f calcium in the 
serunl of tlormal animals was increased to the level that is encountered in tumour-bearing rats, a sharp drop in liposome 
recognition by liver phagocytes was observed. This drop in opsonic activity was not related to changes in the ionic strength 
of serum. The ammonium sulphate precipitated opsonin was also calcium-sensitive and its opsonic activity was abolished in 
the presence of calcium. Sludies with isolated splenic phagocytes suggested that an increase in the opsonic activity of 
serum, but not the elcv:ttcd calcium level, was responsible for hyperphagocytosis of liposomes by the splenic phagocytes of
tumour-transplanted a:limals. The opsonic molecule which enhanced liposome recognition by liver non-parenchymal ,;ells 
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failed to enhance liposome clearance by the splenic phagocytes. These findings suggest that he alteration i  macrophage 
clearance ofliposomes during the terminal growth of cancer may be mediated in part by changes inthe opsonic capacity of 
senlm. 
Kew~'ord.~: Calcium: Chondrosarcoma: Kupffer cell: Liposome: Opsonin: Reticuloendothe!ial system: Splenic macrophage: tRat) 
1, Introduction 
The mechanisms responsible for the recognitioa~ 
and clearance of liposomes by phagocytic cells of the 
reticuloendothelial system from the blood are 
presently not well understood. In rats, it is betieved 
that intravenously administered liposomes of differ- 
ent size, different lipid composition, attd differing 
surface characteristics attract different arrays of blood 
components, the content and conformation of which 
may account for the different pattern in the rate and 
site of vesicle clearance from the circulation [I-I0]. 
The rate and the site of particle clearance from the 
blood is also governed by pathophysiological alter- 
ations in the blood opsonic activity as well as changes 
in macrophage function and responsiveness (e.g., 
changes at the expression of plasma membrane r cep- 
tors and antigens, receptor mobility, macrophage r - 
cruitment) [I !-13]. Earlier we demonstrated that a 
heat-stable proteinaceous factor front rat serum can 
mediate the binding of multilamellar vesicles, com- 
posed of egg phosphatidylcholine (egg PC): choles- 
terol (Chol): dicetyl phosphate (DCP), in a mole ratio 
of 7:2:1, to freshly isolated rat liver phagocytes [6,14], 
The activity of this factor in serum (designated here 
as the liver-specific opsonic molecule) is apparently 
regulated by calcium [14,15]. For instance, prior dial- 
ysis of serum against de-ionized water or the chela- 
tion of serum with EGTA increased its opsonic activ- 
ity by 2- to 3-fold, whereas re-addition of calcium to 
dialyzed or EGTA-chelated serum suppressed the 
elevated opsonic activity as measured on the interac- 
tion of muhilamellar liposomes with isolated rat liver 
macrophages [15]. Furthermore, the opsonic activity 
of serum on liposome recognition by liver non- 
parenchymal cells is abolished at calcium levels above 
the physiological concentration. 
Although calcium at physiological levels is a pre- 
requisite for the process of phagocytosis [15,16], 
Ryder et al. [18] have demonstrated that the elevation 
of serum calcium levels above normal can also in- 
hibit opsono-phagocytosis of lipid emulsions by 
Kupffer cells. Previous analysis of serum ionic com- 
position from experimental nd clinically encoun- 
tered neoplasms have interestingly reported a fie- 
quent pronounced hypercalcaemia during tumour 
growth [18-22]. Upon chemotherapy or surgical re- 
section of the tumour, the calcium levels have been 
reported to return to normal, while tumour ecurrence 
is accompanied bya reappearance of hypercalcaemia 
[19]. Furthermore, studies of Saba and Antikatzides 
[23] on lhe functional state of the reticuloendothelial 
system during turnout growth have revealed that he 
terminal stages of tumour growth and spread (a hy- 
percalcaemic serum state) arc. associated ~,~ith pro 
nounced serum opsonic dysfunction and associated 
depression i hepatic Kupffer cells clearance of parti- 
cles from the blood, 
The above findings when placed in relationship to,, 
the temporal change of calcium levels with tumour 
growth suggest a potential effect of serum calcium 
concentration on reticuloendothelial function. Since 
calcium can regulate opsono-recognition f multi- 
lamellar liposomes composed of egg PC: Chol: DCP 
(mole ratio 7:2:1) by liver non-parenchymal cells 
[14,15], we have now extended our studies to deter. 
mine the role of calcium and serum factors on lipo- 
some recognition and clearance by macrophages of 
the reticuloendothelial system during the terminal 
stages of an experimentally induced non-metastatic 
tt~mour model in rats, 
2. Materials and methods 
2, I. Lipo,wme preparation 
Multilamellar liposomes (300-380 nm average di- 
ameter) containing [125-1]-labelled poly(vinylpyr- 
rolidone) (Amersham, UK), [125-1 PVP], were pre- 
pared from a mixture of egg PC (Lipid Products, 
UK), Chol, and DCP (Sigma Chemicals, UK) in a 
molar ratio of 7:2:1 and 7:7:1 for Chol-poor and 
Chol-rich vesicles, respectively as described earlier 
[i,5]. 
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2.2. Tumour transl)latltatioll 
Male CFY rats, approx. 6 weeks of age, were used 
in all expt ;ments as tumour ecipients. Chondrosar- 
coma [24] (a gilt from Prof. R. Mason. Department of
Biochemistry, Charing Cross Hospital. London) was 
routinely maintained by serial transplant every 4-6 
weeks. Transplantation was accomplished by subcu- 
taneous administration of 2,5 X I04 viable cells in 
sterile Hanks' balanced salt solution, HBSS (Gibco, 
Scotland). in an injection volume of 0.5 ml at each 
flank, Control rats of the same age received only 
HBSS, Full tumour growth occurred in 5-6 weeks 
following transplantation (the total tumour weight 
removed from both flanks was 90 + 24 g). In accor- 
dance with previous observations [24] there was no 
spontaneous regression or sign of metastases in the 
host. Transplanted animals did not show any sign of 
discomfort throughout the experimental period. 
2.3. Liposome administration and biodislribution 
studies 
Groups of 3-4 control and tumour-bearing rats (at 
5-6 weeks post transplantation) were injected intra- 
venously via the tail vein with 15 mg (total lipid) of 
radiolabelled chol-poor liposomes. Rats were killed at 
1 h post-administration of liposomes and the radioac- 
tivity associated with the blood and organs of the 
reticuloendothelial system was measured. To deter- 
mine the amount of liposomes in the blood, we 
assumed a total blood volume per rat of 7.5% body 
weight [I]. Correction factors for the blood content in 
tissues were determined according to the established 
procedures [I25]. 
2.4. Cell isolatio~l aml im'ubation procedures 
Hepatic non-parenchymal cells, containing pre- 
dominantly endothelial and Kupffer cells, and splenic 
white cells were prepared from both control and 
tumour-bearing rats (at the terminal stages of tumour 
growth) as described ila detail elsewhere [5,6]. Details 
of incubation procedures and uptake assessment are 
presenled in full elsewhere [5.6]. Briefly, splenic cells 
(10 '~ cells/ml) were incubated at 37°C for I h with 
liposomes (0.6 nag total lipid) in the absence and 
presence of 259c (v/v) of fresh rat serum (details 
regarding serum preparation and its treatment is re- 
ported elsewhere [15]) in a total volume adjusted to 
2.0 ml with I0 mM oxygenated phosphate-buffered 
saline (pH 7.4) containing 5.0 mM glucose and !.0% 
bovine serum albumin. The incubation media foi 
hepatic cells (lO 7 cells/ml) was the same as that 
described for splenic ceils except that phosphate- 
saline buffer was replaced with calcium/magnesium 
free HBSS. The uptake of radiolabelled PVP wa; 
measured in the cells at the end of the incubation. 
Since free PVP is not degradable and not adsorbed 
onto or taken up by the cells (pinocytic uptake of free 
PVP was not more than 0.2% of the dose for both the 
liver and the spleen phagocytes), the radioactivity 
associated with cells indicates the presence of lipo- 
somes [I,5,6]. The leakage of PVP from liposomes 
was minimum in the presence of 25% (v/v) control 
and tumour-derived sera as well as the cells. Each 
incubation was performed in triplicate (otherwise 
stated) and each experiment was repeated at least 
three times. Because of variation in opso,fic activity 
from animal to animal, the mean results of a typical 
experiment + the standard error is reported. 
2.5. Serum fractionation 
Serum from normal and tumour-bearing rats was 
subjected to ammonium sulphate fractionation in an 
attempt to obtain a fraction containing the liver- 
specific opsonin responsible for enhancing liposome 
recognition by hepatic phagocytes [14]. Regardless of 
their source, the same quantity of serum (in terms of 
mg protein) was used for fractionation. Protein deter- 
mination was made by the Lowry method [26]. Ini- 
tially, serum (pH 7.0) was brought o 35% saturation 
by slow addition, while gently stirring, with solid 
ammonium sulphate at 4°C (pH 7.0-7.2). After the 
complete addition of ammonium sulphate, the sus- 
pension was stirred tor 45 min at 4°C and the precipi- 
tated proteins were removed by centrifugation at 
12000 × g for 15 min, 4°C. To the supernatant from 
the previous step, ammonium sulphate was added 
slowly over 20 min to bring the final saturation to 
50% at 4°C. The mixture was allowed to stir gently 
for an additional hour and the precipitate was re- 
moved by centrifugation as described above. The 
precipitate was dissolved in 10,0 mM Tris-0.15 M 
sodium chloride (pH 7,0) at 4~C and dialyzed exten- 
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sively against he same buffer at 4°C. Finally, 15.0 
mg of the final product was passed through asephadex 
G-200 column (0.7 x 50 cm) equilibrated with 10.0 
mM Tris-O.15 M sodium chloride (pH 7.0) at 4°C. 
The collected fractions were monitored tbr protein by 
measuring the absorbance at 280 nm. The protein- 
containing fractions were tested for opsonic activity 
on liposome recognition by freshly isolated Kupffer 
cells and splenic macrophages and the results are 
expressed as percentage-specific recognition medi- 
ated by fractionated serum proteins. Percentage- 
specific recognition is defined as (A -  B)/(mg of 
fractionated serum protein added), where A and B are 
percentage of initial liposomal radioactivity associ. 
ated with liver cells in the presence and in lhe 
absence of fractionated serum proteins, respectively. 
3. Results 
3, i. Tissue distribution of liposomes 
Wc have found no signilicant chan~cs it, lhe weighl 
of liver between control (9.5 + 1,2 g) and tumour- 
bearing animals (10,1 + 1.0 g) at terminal stage of 
tumour growth. In contrast, the spleen weights from 
tumour-bearing animals (0.71 +_ 0.01 gl were signifi- 
cantly ( P < 0.02) higher than the control rats (0.56 _+. 
0.01). 
The results of tissue distribution of intravenously 
injected liposomes is given in Fig, I. The liver of 
tumour-bearing animals manifests uppressed lipo- 
some uptake when compared to that of normal rats. 
This difference in hepatic uptake between the tv,,o 
groups is significantly clear when the results are 
expressed as percentage of injected dose per gram 
tissue. Thus, the corresponding values are 2.4 4-O. 1 
and 4.0 + 0.1 fo~" tumour-bearing and control rats, 
respectively. In contrast, splenic uptake of liposomes 
was considerably higher in tumour-bearing rats (28.3 
+ 3.0% per gram spleen) than in normal rats (16.2 __. 
3.3% per gram spleen, P < 0.05). Similar to the liver, 
the uptake of liposomes in lung is also suppressed in
tumour-bearing rats. 
3.2. Liposome-lirer cell interaction 
We have compared the opsonic activity of normal 
serum to that derived from tumour-transplanted rats
on liposome interaction w?ih hepatic phagocytes (Fig. 
2), Nt~rmal serum equally enhanced liposome recog- 
nition b', hepatic macrophages of both normal and 
turnout-bearing animals, whereas both cell popula- 
tions manifested poor liposome recognition in the 
presence of serum from tumour-bearing animals (val- 
ues were comparable to the co,responding incuba- 
tions without he serum). Interestingly, the serum of 
tumour-bearing animals when chelated with EGTA or 
previously dialyzed against de-ionized water or saline 
(0.97,; w/v) was able to enhance the interaction of 
liposomes with both cell populations. However, more 
liposomes were found in association with liver cells 
of normal animals than of tumour-bearing rats in the 
presence of the chelated or dialysed serum of 
tumour-tmnsplanted rats (Fig. 2), 
Earlier we demonstrated that dialysed serum can 
enhance the binding of liposomes to Kupffer cells: a 
process that could be due to removal of ionic cal- 
ciun~, or other divalent cations, on dialysis of serum 
[I 5]. The total concentration f calcium in serum, as 
measured by atomic absorption, was found to be 
~,lgnific:t,,tl). higher (:., = IS. P <0.001) in tumour- 
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Fig. I. Biodlstribution f intravenously injected liposome.,~ in 
nomlal and tumour-bearing a imals at I h post-intravenous ad- 
ministration. Radioactivity associated ~'~ith carcass, 20-3t)';~ of
the administered dose in Both groups, may represent liposomal 
radioactivity associated with bone marrow, vascular endothelium. 
skin, gut and to a certain extent the tumour tissue. Black 
column~,: ~orm'al rats, open columns: tun]our-bearing rats. 
r~t) S.M. Moghimi ll.M l'atel / Bim'himicu elBio,~hy.~it'a Ac~ 12,~5 (1996) 56-64 
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Fig. 2. Opso~lic effect of sertlnl, derived from both normal and lumour-bearing rats, and its treatment on liposome interaction wilh liver 
non-p~lrcnchymal cells of normal (:~)and turnout-bearing (b) animals. 
bearing animals (3.00+ 0.08 mM at the terminal 
stages of tumour growth) than in the control animals 
of the same age (2.80_+ 0.03). Therefore, caicium 
concentration i  normal serum was first titrated to the 
level that is found in the serum of tumour-bearing 
rats and then its np'~onic activity was measured, 
When the concentration of calcium in serum wa,,, 
increased by 0.25 mM, liposome recognition by liver 
phagocytes decreased dramatically (Fig. 3a). The op- 
sonic activity of serum was abolished when calcium 
concentration was increased by 0.75 mM (Fig. 3a), in 
order to determine whether this decrease in liposome 
opsono-recognition was due to increase in the ionic 
,~treng~h of medium, similar incubations were per- 
(a) 
1~' 
4' 
01) 05 I[} 
Ol , I . , • I - , 
0.0 I I} 2(} .~ 0 4 O 
]nCrc~,s¢ In scrUtn q;;llclUIh Cr;Ilc¢IIIr~IiOTI {film ) lll¢l!.'asc ill s,:rUTIl s~J~JJUrll ¢htlll'ld¢ ¢ollC¢~lr.~llon I nhM) 
FiL~. 3. lntcradi~m of lipt~som¢~, with hepatic non-parenchymal ¢¢11s t'ollowin~ ¢xperimc,ltal manipulation of ionic slren~lh b) cal¢i,ml 
chloride fit) "rod sodium chloride (b). The arrov, head illdicate,, liposome-cell interaction in the absenu..' of ht~lh rat serum and calcium 
chbride, and lhc arrow indic:lies liptlsome-cell intel';lu'ti~n i the ab~,ence t~t' serun~ hut in the presence ef 3,0 mM calciuTn chloride. 
Becatls¢ of charge diffcrence~,, a ~,~ldium chloride .,,olulion Ihree times as coucentraled :in calcium chloride st~lution has the same ionic 
MI¢II~I!I, Li~¢1 cells ~lC I'I~3111 k:Olll1"tlI [ills. 
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Table I
Opsonic activity of serum prc, teirt,; precipitaled b~ ammonium 
sulphate on liposome r cc, gnition by liver non-parench.vmal cells 
Ammonium sulphate saturation level (%) '7;- specific 
Ieco,gnilion 
I. Serum of tumour t ansplanted rats: 
35-50% precipitate 2.5 +_ 0.5 
35-50rk supernatent 03 + O.U5 
II. Serum of healthy rat~: 
35-50% precipitate 3.9 _* 1~. I 
35-50c,~ - supernatent I)9 +_ 0 I 
Liver non-parenchymal cel s were obtained from hcahh~ rat:,. 
Incubations contained 5.[1-7.0 mg serum protein. 
For both sera, the malcrials precipitated in the range of 0-35'; 
ammonium sulphate had ,lo op:,onic activiL,, anti failed to pro- 
mote liposome r cognition by liver cell.,,. 
lbrmed but sodium chloride at a concentration three 
timea higher than calcium chloride (equivalent o 
same ionic strength) replaced calcmm chloride. 
Changes in liposome--cell interaction observed in the 
sodium chloride-supplemented samples were indeed 
minimum (Fig. 3b). We also studied the effect of 
increasing concentrations of calcium on the interac- 
tion of liposomes with liver cells, but in the absence 
of serum, and lbund no significant changes on lipo- 
some-ceU interaction upon the addition of calcium 
(data not shown). 
Serum from healthy and lump':r-bearing rats was 
subjected to ammonium sulphate fractionation in an 
attempt o obtain a proteinaceous component capable 
of enhancing liposome recognition by hepatic phago- 
cytes. In a series of ammonium sulpb t "ractionation 
studies, we found that a serum pro,c ,, factor, precip- 
itable by 35-50ek ammonium sulphate, can enhance 
liposome recognition by liver cells (Table I). Lipo- 
some recognition by liver phagocytes was more en- 
hanced in the presence of the precipitated factor from 
the control animals than that of tumour-bearing rats 
(Table I}. To further purify the opsonic molecule 
from both sera. the 35-50% ammonium sulphate-pre- 
cipitated materials were passed through a sephadex 
G-200 column. Although the A280 profiles looked so 
different (Fig. 4), the opsonic activity was confined 
to the second peak in both sera (with optimum activ- 
ity occurring in fraction 20 regardless of serum 
source). 
In a separate series of experiments, we found that 
the uptake of liposomes by liver cells in the presence 
of the partially-purified op,';onin (pooled from frac- 
tion 20 and 21, Fig. 4a) was temperature-dependent 
and could be inhibited at a low temperature (4°C) of 
incubation (data not shown). Furthermore, at 37°C 
and in the presence of the partially-purified opsonin. 
the phagocytic inhibitor cytochalasirt B reduced the 
association of liposomai aqueous marker with liver 
cells by 40')L In accordance with the above observa- 
I(} 20 = 
II / 11 
III 2fl t(} 
15-  
05 
[ ]0 '  
I<1 
(o) Serum of a normal rat 
2O 
FrllcliOll number 
Fraction number 
O 
3O 
--..o--- A280 
Ib) Serum of a lumour-bearing rat 
g 
a, 
'2 t"~ 
% Specific rec,agniu,m 
Fig. 4. Elation profiles of sertml proteins precipil.'lted by35-5(1~)~ 
allmlunlum sulphate on a sephadex G-2I)O cohlfult. Percentage 
~,pecit'ic recognitmn of liposomes by liver tmn-parertchymal cells 
is al,,~ indicated (the results are the meart of duplicate incuha- 
lions: illdividual values were within 5¢~ of the Illean value. 
Incubations, contaitled 0.3-0.6 mg serun'l protein. Dupli~:ate illctl- 
batiun~, contained the same quantity of serum proteins). Liver 
nOl~-parench',mal cells were derived from normal animals. For 
experimental details ee Section 2. 
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Fig. 5. Op.,,onic effect of normal and lest (turrtour-derived) sera 
on Iiposornc inleractkm with splenic phagocytic ells lit" nurln;,ll 
and lunlour-hearing arfirnals+ Opsoni¢ activity tlf serum '.'aricd 
from aninlal to animal but in all separate experimellt~, Iht: opsonic 
aclMly of serum derived lrt~m tuillour-transplallted rats was 
si,dnificantly higher than that ~1" healthy rats, The results pre- 
~.ented i,r d~e IllCtlll ~.)f three inctthations+the s alldard error of 
one typical experimenl {i,e.. spleen cells :and serur;, was t'roirl Ihe 
same animal). 
lions, the partially-purified opsonin was calcium-sen- 
sitive; its opsonic activity was reduced by approx. 
40% in liver cell incubations upplernerlted with 0.5 
mM calcium chloride. The presence of l.0 mM cal- 
cium chloride, however, totally abolished the opsonic 
activity of the partially-purified protein. 
3.3. Lil~o.scmle-,~7~h, en c'c'll iuterarti~nl 
Serum is known to stimulate the interaction of 
both chol-poor and chol-rich vesicles by the splenic 
phagocytt:s, but its effect is siDfificantly greater c,n 
the uptake ~t' chol-rich liposomes [5.6]. Hence, we 
tested the opsonic activity of both control and tu- 
mour-derived sera on interaction of chol-rich lipo- 
some with the splenic phagocytes. The resuhs in Fig. 
5 shows that both normal and tumou,'-derived sera 
can stimuh~te liposome irtteraction with spleen cells 
of bol',, hernial and tulnour-be~.lring animals. The 
opsonic actMiy of serum fronl lUnlour-hearing ani- 
mals is 4()ok hither than th~ii of normal serum in 
promolin,~ liposoni¢ clear;.illCC by both cell poptila- 
tions. Furthermore, the opsonic molecule which en- 
hanced liposome recognition by Kupffer cells {i.e., 
fractions with the highest activity in sephadex G-200 
colt~mn) failed to enhance liposome clearance (re- 
gardless of their cholestercl content) by the splenic 
phagocytes (data not shown). 
4. Discussion 
The current investigation demonstrates a good cor- 
relation between the in rive results of liposome 
distribution at the terminal growth phase of chon- 
drosarcoma nd the in vitro cellular assay systems. 
The diminished clearance of liposomes by Kupffer 
cells during the terminal phase of tumour growth 
could be correlated with the activity of a serum 
opsonin precipitable by 35-50% ammonium sulphate 
(Table i and Fig. 4). Earlier, we demonstrated that 
the activity of this liver-specific opsonin is regulated 
by calcium [I 5]. An increase in physiological concen- 
tration of calcium will suppr.ss and a decrease will 
enhance its activity with regard to the recognition of 
rnultilamellar liposomes (composed of egg PC: Chol: 
DCP. in a mole ratio of 7:2:1) by freshly isolated rat 
liver macrophages in suspension (see also Fig. 3). 
The findings reported here (Figs. I-3) suggest hat 
the elevated levels of calcium in the blood at terminal 
stages of tumour growth can suppress opsono-recog- 
nition of liposomes by the liver phagocytes. Although 
there was no sign of metastases in the host, differ- 
ences were observed between the liver phagocytes of 
normal and tumour-transplanted rats with regard to 
liposome recognition in the presence of dialyzed or 
EGTA-treated serum of tumour-bearing animals. 
Therefore, we cannot exclude the possibility of cer- 
lain changes associated with liver macrophages that 
can affect opsono-recognition f liposomes in cancer. 
Nevertheless, the results of liposome recognition by 
Kupffer cells are ill close agreement with the earlier 
observations of Ryder et al, [17] and Saba and An- 
tikatzides [23]. ahhough the nature of the opsonic 
molecule and the test particles are different between 
the present and these reported studies. These investi- 
,daters [I723] used gelatin-coated lipid emulsions as 
the phagocytic substr;.lte and the responsible opsonin 
has been identified as fibronectin. Otir previous ob- 
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servations disregarded fibronectin as an opsonin re- 
sponsible for the recognition of multilamellar lipo- 
somes by isolated rat Kupffer cells [6}. 
The enhanced liposome clearance by the spleen in 
tumour-bearing rats can be closely correlated to an 
increase in the opsonic activity of serum, since splenic 
phagocytes from both normal and tumour-bearing 
rats manifest liposome hyperphagocytosis in the pres- 
ence of serum derived from tumour-bearing animals 
when compared to control serum. The increased op- 
sonic activity in the serum from tumour, transplanted 
rats is unlikely to be due to elevated levels of cal- 
cium, since the addition of calcium to normal serum 
to the level that is encountered in tumour-bearing 
animals did not have a significant effect on liposorne 
recognition by both cell types (data not shown), 
Furthermore. unlike liver phagocytes, spleen cells 
manifest hypophagocytosis n the presence of 
EGTA-chelated and dialysed sera and the addition of 
calcium to such sera fails to fully restore the lost 
opsonic activity [15]. These observations therefore 
support our earlier suggestion that blood may con- 
tains opsonins which exhibit issue-specificity: at least 
with respect to recognition and the clearance of 
DCP-containing egg PC vesicles of different choles- 
terol content by hepatic and splenic phagocytic cells, 
respectively [5,6,15]. 
Previous studies have shown elevated lung uptake 
and poor hepatic localization of technetium tin col- 
loid (TTC) in numerous malignant anti benign ills- 
eases, particularly in those of tae chest region [27]. In 
contrast, enhanced bone marrow uptake of TTC was 
noted in patients with gastrointestinal malignancies, 
whereas patients with lymphoreticular malignancies 
seemed to cause abnormally increased spleen uptake 
of TTC [27]. The cause for these discrepancies has 
been hypothesized to be related to regional sfimuht- 
tion of the macrophages by the tumeur [27]. How- 
ever, in the light of the present study we additionally 
propose that altered tissue distribution of colloidal 
particles in various malignancies may be due to 
changes in the activity of tissue-sp~,cific opsonins 
induced by factors uch as the elevated blood calcium 
levels. For instance, it is likely that an increase in 
levels of calcium concentration i the blood may 
have suppressed TIC clearance by Kupffer cells in 
cancer patients, since hypercalcaemia is known to be 
associated with both primary and metastatic lung 
carcinoma ~s well us in breast carcinoma [22]. The 
enhanced clearaace of "FfC by other organs of the 
reticuloendothelial system could also be the result of 
c!cvated activity of those opsonins which exhibit 
phagocyte specificity. The relationship of the present 
observatioas to disturbances of the macrophage sys- 
tem during malignancy, which is known for its ability 
to alter the serum calcium concentration, warrants 
furthec invest;gation. 
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